This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Karo Pharma Management

Management criteria checks 1/4

Key information

Christoffer Lorenzen

Chief executive officer

kr12.6m

Total compensation

CEO salary percentage35.8%
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Karo Pharma (STO:KARO) Has No Shortage Of Debt

Oct 14
Karo Pharma (STO:KARO) Has No Shortage Of Debt

Is Karo Pharma (STO:KARO) A Risky Investment?

Jul 10
Is Karo Pharma (STO:KARO) A Risky Investment?

Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt

Mar 23
Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt

Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality

Feb 24
Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality

Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?

Feb 22
Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?

Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?

Feb 01
Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?

CEO Compensation Analysis

How has Christoffer Lorenzen's remuneration changed compared to Karo Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-kr190m

Mar 31 2022n/an/a

-kr141m

Dec 31 2021kr13mkr5m

-kr17m

Sep 30 2021n/an/a

kr63m

Jun 30 2021n/an/a

kr2m

Mar 31 2021n/an/a

kr49m

Dec 31 2020kr12mkr5m

kr82m

Sep 30 2020n/an/a

kr86m

Jun 30 2020n/an/a

kr87m

Mar 31 2020n/an/a

kr55m

Dec 31 2019kr16mkr2m

kr9m

Compensation vs Market: Christoffer's total compensation ($USD1.20M) is above average for companies of similar size in the Swedish market ($USD901.38K).

Compensation vs Earnings: Christoffer's compensation has increased whilst the company is unprofitable.


CEO

Christoffer Lorenzen (47 yo)

3.3yrs

Tenure

kr12,564,000

Compensation

Mr. Christoffer Lorenzen has been the Chief Executive Officer of Karo Pharma AB since July 1, 2019. Mr. Lorenzen was an Executive Vice President of Food Cultures & Enzymes at Chr. Hansen Holding A/S from A...


Leadership Team

NamePositionTenureCompensationOwnership
Christoffer Lorenzen
Chief Executive Officer3.3yrskr12.56mno data
Jon Johnsson
Chief Financial Officer3.1yrsno datano data
Jonathan Kimber
Vice President of Operations3.2yrsno datano data
Sofia Kyhlstedt
Vice President of Scientific Affairsno datano datano data
Lisa Westerdahl
VP of Commercial Pharma Operations & Corporate Communicationsno datano datano data
Anna Hale
Chief Marketing Officer1.8yrsno datano data
Karin Lindberg
Head of People & Organization2.5yrsno datano data
SIMON Nyberg-Hansen
Managing Director of Norwayno datano datano data
Fredrik Thorsen
Head of Digital & E-commerce1.5yrsno datano data
Matt Roberts
Chief Commercial Officer1.2yrsno datano data
Robin List
Chief Executive Officer of Sylpharless than a yearno datano data
Anna Elmblad
Vice President of Digital Marketingno datano datano data

2.2yrs

Average Tenure

47yo

Average Age

Experienced Management: KARO's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Keatley
Independent Director1.6yrskr413.00kno data
Uta Kemmerich-Keil
Independent Director2.5yrskr394.00kno data
Erika Henriksson
Director3.8yrskr394.00kno data
Flemming Ørnskov
Independent Director3.1yrskr394.00kno data
Kristofer Tonström
Independent Director2.5yrskr394.00kno data
Patrick Smallcombe
Independent Chairman1.6yrskr552.00kno data
Claire Hennah
Independent Directorless than a yearno datano data

2.5yrs

Average Tenure

56yo

Average Age

Experienced Board: KARO's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.